Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Women only

Accelerated theta burst treatment for postpartum depression

Official title: An Open Label Study to Assess the Feasibility and Tolerability of Accelerated Theta Burst Repetitive Transcranial Magnetic Stimulation (iTBS-rTMS) for the Treatment of Post-Partum Depression

Run by Medical University of South Carolina · NCT03417960 · Data updated 2026-11-12

This study is testing a new treatment using brain stimulation for women with postpartum depression to see if shorter sessions can help them feel better.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment40 (estimated)
SponsorMedical University of South Carolina
Academic / other
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedJanuary 24, 2018
Main results expectedAugust 30, 2027
Study endsAugust 30, 2027
Registry record updatedMay 22, 2026
Trial IDNCT03417960 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women over 18 who have been diagnosed with postpartum depression within the first year after childbirth.

Probably not a fit

Patients who are currently pregnant, have severe substance use disorders, or exhibit active psychotic symptoms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the feasibility and tolerability of intermittent theta burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex for women suffering from postpartum depression. Participants will undergo either 10 sessions per day over 6 days or 12 sessions per day over 5 days to assess the antidepressant effects of these treatment schedules. The goal is to determine if a shorter treatment duration is more acceptable and effective for this population compared to traditional longer protocols. The study aims to gather data that could inform larger future trials.

Why it matters

Potential benefit: If successful, this treatment could provide a rapid and effective intervention for women experiencing postpartum depression.

How similar studies have gone: While transcranial magnetic stimulation has been shown to effectively treat depression, this specific approach using accelerated iTBS is novel and has not been extensively tested in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants must be able to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments.
2. Participants must be over the age of 18.
3. Participants must meet criteria for post-partum depression: a) onset of symptoms in the first year postpartum
4. Participants must have a HRSD17 greater than or equal to 14 at baseline.

Exclusion Criteria:

1. Participants must not be pregnant.
2. Participants must not meet moderate or severe use disorder of any substance with the exception of Tobacco Use Disorder.
3. Participants must not have current psychotic symptoms.
4. Participants must not have a history of dementia or other cognitive impairment.
5. Participants must not have active suicidal ideation requiring hospitalization or a suicide attempt within the past 3 months.
6. Participants must not have any contraindications to receiving rTMS (e.g. metal implanted above the neck, history of seizure, any known brain lesion).
7. Participants must not have any unstable general medical conditions.
8. Participants must not have had eclampsia during pregnancy.

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.